Senestech (NASDAQ:SNES) Stock: Insider Glenbrook Capital Management Purchases 28,000 Shares

Senestech, Inc. (NASDAQ:SNES) major shareholder Glenbrook Capital Management bought 28,000 shares of the business’s stock in a transaction dated Wednesday, October 28th. The shares were bought at an average cost of $0.97 per share, for a total transaction of $27,160.00. Following the completion of the transaction, the insider directly owned 2,194,973 shares of the company’s stock, valued at $2,129,123.81. This trade represents a 1.29% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Glenbrook Capital Management also recently made the following trade(s):

• On Friday, October 30th, Glenbrook Capital Management bought 2,000 shares of Senestech stock. The shares were bought at an average cost of $1.02 per share, with a total value of $2,040.00.
• On Thursday, October 22nd, Glenbrook Capital Management purchased 7,500 shares of Senestech stock. The stock was bought at an average price of $0.80 per share, with a total value of $6,000.00.
• On Wednesday, October 21st, Glenbrook Capital Management purchased 60,000 shares of Senestech stock. The stock was bought at an average price of $0.74 per share, with a total value of $44,400.00.
• On Tuesday, October 20th, Glenbrook Capital Management purchased 36,375 shares of Senestech stock. The stock was bought at an average cost of $0.67 per share, for a total transaction of $24,371.25.
• On Monday, October 19th, Glenbrook Capital Management acquired 376,552 shares of Senestech stock. The shares were bought at an average price of $0.70 per share, for a total transaction of $263,586.40.
• On Friday, October 16th, Glenbrook Capital Management acquired 181,252 shares of Senestech stock. The shares were bought at an average price of $0.63 per share, for a total transaction of $114,188.76.
• On Thursday, October 15th, Glenbrook Capital Management acquired 426,000 shares of Senestech stock. The shares were purchased at an average cost of $0.77 per share, with a total value of $328,020.00.
• On Friday, August 7th, Glenbrook Capital Management bought 6,490 shares of Senestech stock. The stock was purchased at an average price of $1.30 per share, with a total value of $8,437.00.
• On Thursday, August 6th, Glenbrook Capital Management bought 15,000 shares of Senestech stock. The stock was purchased at an average price of $1.30 per share, with a total value of $19,500.00.

Senestech Stock Performance

Shares of SNES opened at $1.08 on Friday. The company has a 50-day moving average of $0.85 and a two-hundred day moving average of $1.49. The stock has a market cap of $5.85 million, a price-to-earnings ratio of -0.79 and a beta of 0.25. The company has a debt-to-equity ratio of 0.02, a current ratio of 6.78 and a quick ratio of 5.81. Senestech, Inc. has a one year low of $0.55 and a one year high of $3.61.

Senestech (NASDAQ:SNES) last released its quarterly earnings results on Wednesday, August 5th. The company reported ($0.35) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.37) by $0.02. The business had revenue of $0.77 million for the quarter, compared to analyst estimates of $0.60 million. Senestech had a negative net margin of 294.73% and a negative return on equity of 71.89%. On average, equities research analysts expect that Senestech, Inc. will post -1.27 earnings per share for the current year.

Hedge Funds Weigh In On Senestech

An institutional investor recently bought a new position in Senestech stock. Diversify Wealth Management LLC acquired a new stake in Senestech, Inc. (NASDAQ:SNES) during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 19,119 shares of the company’s stock, valued at approximately $31,000. Diversify Wealth Management LLC owned 0.36% of Senestech as of its most recent filing with the SEC. 5.19% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Weiss Ratings downgraded shares of Senestech from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Tuesday, August 11th. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the company has an average rating of “Sell”.

Senestech Company Profile

SenesTech, Inc is a biotechnology company focused on developing fertility-control technologies for managing animal populations. The company’s approach is designed to reduce reproduction rather than rely solely on lethal control methods, with applications primarily in rodent management.

SenesTech’s principal product is ContraPest, a liquid bait designed to reduce fertility in rats by affecting reproductive function in both male and female animals. The product is intended for use in commercial, municipal and other settings where rat populations pose sanitation, health or property risks.